| HSP90 inhibition enhances cancer immunotherapy by modulating the surface expression of multiple immune checkpoint proteins RB Zavareh, SH Spangenberg, A Woods, F Martínez-Peña, LL Lairson Cell chemical biology 28 (2), 158-168. e5, 2021 | 57 | 2021 |
| A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer NC Lucki, GR Villa, N Vergani, MJ Bollong, BA Beyer, JW Lee, JL Anglin, ... Proceedings of the National Academy of Sciences 116 (13), 6435-6440, 2019 | 28 | 2019 |
| Protocol for high-throughput compound screening using flow cytometry in THP-1 cells SH Spangenberg, RB Zavareh, LL Lairson STAR protocols 2 (2), 100400, 2021 | 3 | 2021 |
| Hydroxyproline metabolism enhances IFN-γ-induced PD-L1 expression and inhibits autophagic flux SH Spangenberg, A Palermo, NR Gazaniga, F Martínez-Peña, C Guijas, ... Cell chemical biology 30 (9), 1115-1134. e10, 2023 | 1 | 2023 |
| Identification of Mechanisms Regulating Expression of PD-L1 and Other Immune Checkpoint Proteins Using Chemical Biology Approaches SH Spangenberg The Scripps Research Institute, 2023 | | 2023 |
| STEM-20. A CANCER STEM CELL-SELECTIVE APOPTOSIS-INDUCING SMALL MOLECULE FOR THE TREATMENT OF GBM S Skirboll, N Lucki, G Villa, N Vergani, M Bollong, B Beyer, JW Lee, ... Neuro-Oncology 22 (Supplement_2), ii200-ii200, 2020 | | 2020 |
| A Network of Endogenous Metabolites Modulates Programmed Death-Ligand 1 (PD-L1) Expression in Monocytic Leukemia A Palermo, S Spangenberg, C Guijas, L Lairson, G Siuzdak Biophysical Journal 116 (3), 308a, 2019 | | 2019 |
| Programmed Death-Ligand 1 (PD-L1) Metabolic Modulation Provides Mechanistic and Therapeutic Insight A Palermo, S Spangenberg, C Guijas, L Lairson, G Siuzdak MOLECULAR BIOLOGY OF THE CELL 29 (26), 267-267, 2018 | | 2018 |
